CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis.

doi:10.1097/MD.0000000000019433

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis.

Medicine - 1 Mar 2020

Hu ShiWan, Pu Dan, Xia XueYi, Guo BeiXi, Zhang ChuanLi

Abstract excerpt

BACKGROUND: Number of studies have been performed to evaluate the relationship between the cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) gene variant rs5742909 polymorphism and cervical cancer risk, but the sample size was small and the results were conflicting. This meta-analysis was conducted to comprehensively evaluate the overall association. METHODS: PubMed, Web of Science, Embase, China Biology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to CTLA-4 Antigen
Share to Genetic Predisposition to Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 32176070
DOI: 10.1097/MD.0000000000019433
PMCID: PMC7220313

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Uterine Cervical Neoplasms